274 related articles for article (PubMed ID: 9303569)
21. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.
Bruinvels AT; Landwehrmeyer B; Probst A; Palacios JM; Hoyer D
Brain Res Mol Brain Res; 1994 Jan; 21(1-2):19-29. PubMed ID: 8164519
[TBL] [Abstract][Full Text] [Related]
22. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
[TBL] [Abstract][Full Text] [Related]
23. Differences in ligand binding profiles between cloned rabbit and human 5-HT1D alpha and 5-HT1D beta receptors: ketanserin and methiothepin distinguish rabbit 5-HT1D receptor subtypes.
Bard JA; Kucharewicz SA; Zgombick JM; Weinshank RL; Branchek TA; Cohen ML
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):237-44. PubMed ID: 8878052
[TBL] [Abstract][Full Text] [Related]
24. Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand.
Bonaventure P; Schotte A; Cras P; Leysen JE
Recept Channels; 1997; 5(3-4):225-30. PubMed ID: 9606727
[TBL] [Abstract][Full Text] [Related]
25. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors.
Audinot V; Newman-Tancredi A; Cussac D; Millan MJ
Neuropsychopharmacology; 2001 Sep; 25(3):410-22. PubMed ID: 11522469
[TBL] [Abstract][Full Text] [Related]
26. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
[TBL] [Abstract][Full Text] [Related]
27. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord.
Castro ME; Pascual J; Romón T; del Arco C; del Olmo E; Pazos A
Neuropharmacology; 1997; 36(4-5):535-42. PubMed ID: 9225278
[TBL] [Abstract][Full Text] [Related]
28. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses.
Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ
Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels PJ; Palmier C; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.
Zgombick JM; Bard JA; Kucharewicz SA; Urquhart DA; Weinshank RL; Branchek TA
Neuropharmacology; 1997; 36(4-5):513-24. PubMed ID: 9225276
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.
Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR
Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663
[TBL] [Abstract][Full Text] [Related]
32. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
33. [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra.
Nowak HP; Mahle CD; Yocca FD
Br J Pharmacol; 1993 Aug; 109(4):1206-11. PubMed ID: 8401931
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation.
Kiel S; Brüss M; Bönisch H; Göthert M
Pharmacogenetics; 2000 Oct; 10(7):655-66. PubMed ID: 11037806
[TBL] [Abstract][Full Text] [Related]
35. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
36. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
38. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
[TBL] [Abstract][Full Text] [Related]
39. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.
Waeber C; Moskowitz MA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):263-75. PubMed ID: 8584041
[TBL] [Abstract][Full Text] [Related]
40. Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT.
Grånäs C; Nordquist J; Mohell N; Larhammar D
Eur J Pharmacol; 2001 Jun; 421(2):69-76. PubMed ID: 11399261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
